Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long term application of r-hirudin in a haemodialysis patient

Wiener Klinische Wochenschrift

Volumn 109, Issue 10, 1997, Pages 354-358

  Nowak, Götz ^a,d   Bucha, Elke ^a   Brauns, Ingo ^b   Czerwinski, Ralf ^c  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Dialysis Centre   (Germany)

^c HELIOS KLINIKUM ERFURT   (Germany)

^d NONE   (Germany)

Author keywords

anticoagulation; haemodialysis therapy; heparin induced thrombocytopenia type II; hirudin

Indexed keywords

ENOXAPARIN; HEPARIN; LEPIRUDIN;

AGED; ANTICOAGULATION; ARTICLE; CASE REPORT; DRUG SAFETY; DRUG TOXICITY; FEMALE; HEMODIALYSIS; HUMAN; THROMBOCYTOPENIA;

EID: 0030971368     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kikta MJ, Keller MP, Humphrey PW, Silver D (1993) Can low molecular weight heparins and heparinoids be safely given to patients with heparin induced thrombocytopenia syndrome. Surgery 114: 705-710
2. Neuhaus KL, v Essen R, Tebbe U, Jessel A, Heinrichs H, Maurer W (1994) Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. Circulation 90:1638-1642
3. Topol EJ, Fuster V, Harrington RA, Califf RM, Kleiman NS, Kereiakes DJ (1994) Recombinant hirudin for unstable angina pectoris: A multicenter, randomized angiographic trial. Circulation 89:1557-1566
4. The Global Use of Strategies To Open Occluded Coronary Arteries (GUSTO) Ha Investigators (1994) Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. Circulation 90: 1631-1637
5. Nowak G, Bucha E, Gööck T, Thieler H, Markwardt F (1992) Pharmacology of r-hirudin in renal impairment. Thromb Res 66: 707-715
6. Nowak G, Bucha E (1996) Quantitative determination of hirudin in blood and body fluids. Sem Thromb 22: 197-202
7. Nowak G, Bucha E, Czerwinski R, Thieler H (1995) Hirudin - a new anticoagulant in haemodialysis (HD). Pharm Res 31 [Suppl]:335
8. Linde N, Tsakiris DA, Vogt A, Marbet GA (1991) Heparin-induzierte Thrombozytopenie. Perspektiven in einem therapeutischen Dilemma. VASA 20: 157-163
9. Lapka DM, Wild LD, Barbour LA (1994) Heparin-induced thrombocytopenia and thrombosis: a case study and clinical overview. Oncology Nursing Forum 21: 871-876
10. Cola C, Ansell J (1990) Heparin-induced thrombocytopenia and arterial thrombosis. Alternative therapies. Am Heart J 119: 368-374
11. Nand S (1993) Hirudin therapy for heparin-associated thrombocytopenia and deep venous thrombosis. Am J Hematol 43: 310-311
12. Thieler H, Gööck T, Nowak G (1991) Ist Hirudin als Antikoagulans bei dialysepflichtigen Patienten geeignet? Nieren- und Hochdruckkrankheiten 20: 453
13. Vanholder RC, Camez AA, Veys NM, Soria J, Mirshahi M, Soria C, Ringoir S (1994) Recombinant hirudin: a specific thrombin inhibiting anticoagulant for hemodialysis. Kidney Int 45: 1754-1759
14. Bucha E, Nowak G, Kreml R (1996) In vitro study of rhirudin permeation through different types of dialyzer membranes (in preparation) in press